… ProQR to Present Interim Phase 1/2 Results for QR-110 in … and will be made available in the “Investors” section of ProQR’s website ( www.proqr.com ) under “Events and Presentations”. About …
… ProQR Announces Positive Interim Results from Phase 1/2 … & CAMBRIDGE, Mass., Sept. 05, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to … executive vice president of research and development of ProQR. “We observed a clinically meaningful improvement in …
… ProQR Therapeutics Teams Up with the Foundation Fighting … and CAMBRIDGE, Mass, Feb. 06, 2020 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to … for IRDs. Daniel de Boer, Chief Executive Officer of ProQR, said, “We are honored to be the first industry partner …
… ProQR Receives up to $5 Million in Partnership with EB … LEIDEN, the Netherlands, June 12, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to … said Daniel A. de Boer, Chief Executive Officer of ProQR. “With the funding from these partners, we plan to …
… ProQR annonce des résultats intermédiaires positifs pour un … Massachusetts, 05 sept. 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), une entreprise qui … vice-président exécutif recherche et développement de ProQR. « Nous avons observé une amélioration cliniquement …